Abstract
Aim: This study presents an improved method based on “Gorji et al. Neuroscience. 2015” by introducing a relatively new classifier—linear regression classification.
Method: Our method selects one axial slice from 3D brain image, and employed pseudo Zernike moment with maximum order of 15 to extract 256 features from each image. Finally, linear regression classification was harnessed as the classifier. Results: The proposed approach obtains an accuracy of 97.51%, a sensitivity of 96.71%, and a specificity of 97.73%. Conclusion: Our method performs better than Gorji’s approach and five other state-of-the-art approaches.Keywords: Alzheimer’s disease, linear regression classification, pseudo Zernike moment.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Alzheimer’s Disease Detection by Pseudo Zernike Moment and Linear Regression Classification
Volume: 16 Issue: 1
Author(s): Shui-Hua Wang, Sidan Du, Yin Zhang, Preetha Phillips, Le-Nan Wu, Xian-Qing Chen and Yu-Dong Zhang
Affiliation:
Keywords: Alzheimer’s disease, linear regression classification, pseudo Zernike moment.
Abstract: Aim: This study presents an improved method based on “Gorji et al. Neuroscience. 2015” by introducing a relatively new classifier—linear regression classification.
Method: Our method selects one axial slice from 3D brain image, and employed pseudo Zernike moment with maximum order of 15 to extract 256 features from each image. Finally, linear regression classification was harnessed as the classifier. Results: The proposed approach obtains an accuracy of 97.51%, a sensitivity of 96.71%, and a specificity of 97.73%. Conclusion: Our method performs better than Gorji’s approach and five other state-of-the-art approaches.Export Options
About this article
Cite this article as:
Wang Shui-Hua, Du Sidan, Zhang Yin, Phillips Preetha, Wu Le-Nan, Chen Xian-Qing and Zhang Yu-Dong, Alzheimer’s Disease Detection by Pseudo Zernike Moment and Linear Regression Classification, CNS & Neurological Disorders - Drug Targets 2017; 16 (1) . https://dx.doi.org/10.2174/1871527315666161111123024
DOI https://dx.doi.org/10.2174/1871527315666161111123024 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
G-Lymphatic, Vascular and Immune Pathways for Aβ Clearance Cascade and Therapeutic Targets For Alzheimer’s Disease
Combinatorial Chemistry & High Throughput Screening Histamine H3 Receptor (H3R) Antagonists and Inverse Agonists in the Treatment of Sleep Disorders
Current Pharmaceutical Design Resurrecting Clinical Pharmacology As a Context for Alzheimer Disease Drug Development
Current Alzheimer Research Does Religiosity Protect Against Cognitive and Behavioral Decline in Alzheimers Dementia?
Current Alzheimer Research Reconstructing the Hsp90/Tau Machine
Current Enzyme Inhibition Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and LDopa Treatment
Current Genomics Effects of SORL1 Gene on Alzheimer's Disease. Focus on Gender, Neuropsychiatric Symptoms and Pro-Inflammatory Cytokines
Current Alzheimer Research Association of Red Blood Cell Indices with Mild Cognitive Impairment in Chinese Elderly Individuals: A Matched Case-control Study
Current Alzheimer Research Traumatic Brain Injury: A Forensic Approach: A Literature Review
Current Neuropharmacology Bioactivities of Iridoids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Editorial: Cocaine and Cerebral Small Vessel: Is it a Negative Factor for Intravenous Thrombolysis?
Current Vascular Pharmacology Phosphodiesterase-4 Modulation as a Potential Therapeutic for Cognitive Loss in Pathological and Non-Pathological Aging: Possibilities and Pitfalls
Current Pharmaceutical Design Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce Amyloid-β Ex Vivo Activation of Peripheral Chemo-cytokines From Alzheimer's Disease Subjects: Exploring the Cholinergic Anti-inflammatory Pathway
Current Alzheimer Research Evidence for Pleiotropic Effects of Statins in Clinical Trials
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Economic Aspects on Drug Therapy of Dementia
Current Pharmaceutical Design Cardiac Workup of Ischemic Stroke
Current Cardiology Reviews HIV-1 TAR RNA: The Target of Molecular Interactions Between the Virus and its Host
Current HIV Research The Role of Biologically Active Ingredients from Chinese Herbal Medicines in the Regulation of Autophagy in Treating Cardiovascular Diseases and Other Chronic Diseases
Current Pharmaceutical Design Differential Influence of Carotid Stenosis and White Matter Disease on Motor and Cognitive Activation
Current Alzheimer Research The Role of Intranasal Oxytocin in the Treatment of Patients with Schizophrenia: A Systematic Review
CNS & Neurological Disorders - Drug Targets